Tech Company Financing Transactions
Stratos Genomics Funding Round
On 5/13/2014, Stratos Genomics raised $10 million in investment from private investors.
Transaction Overview
Company Name
Announced On
5/13/2014
Transaction Type
Venture Equity
Amount
$9,999,999
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2401 Elliott Ave. 5th Floor
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Overview
Stratos Genomics mission is to establish the next gold standard of DNA sequencing with its flagship Sequencing by Expansion (SBX) method. SBX is a simple, elegant, single-molecule detection process that circumvents the limitations of competing technologies, allowing accurate, ultra-low-cost whole genome sequencing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Allan Stephan
Chief Operating Officer
Dick Burger
President
Sean MacLeod
VP - Engineering
John Havard
VP - Operations
Mike Curneen
Browse more venture capital transactions:
Prev: 5/13/2014: Ceterix Orthopaedics venture capital transaction
Next: 5/13/2014: Lysosomal Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs